EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cyclovirobuxine D suppresses gastric cancer growth by targeting the V-ATPase complex and inducing excessive endo-lysophagy

Chongyang Li, Minghao Xu, Yacong Ji, Chaowei Deng, Sicheng Wan, Xiangfei Ding, Kui Zhang, Erhu Zhao, Guangzhao Pan, Xin Hu, Changhong Li, Haoyan Ji und 3 weitere

Journal of Pharmaceutical Analysis · 2026-10 · 16 (10) · 101672

DOI: 10.1016/j.jpha.2026.101672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-10. Verfasst von Chongyang Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Resource Insects, Medical Research Institute, Southwest University, Chongqing, 400716, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Science and Technology Major Project of Guangxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CVB-DChemotherapy resistanceCisplatinEndo-lysophagyGastric cancer

Autor:innen und Institutionen

  • State Key Laboratory of Resource Insects, Medical Research Institute, Southwest University, Chongqing, 400716, China.
  • Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.
  • Jinfeng Laboratory, Chongqing, 400715, China.
  • Department of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai Municipality
  • Science and Technology Major Project of Guangxi
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Hebei Province

Zitieren

APA

Li, C., Xu, M., Ji, Y., Deng, C., Wan, S., Ding, X., Zhang, K., Zhao, E., Pan, G., Hu, X., Li, C., Ji, H., Hu, X., Shi, S., & Cui, H. (2026). Cyclovirobuxine D suppresses gastric cancer growth by targeting the V-ATPase complex and inducing excessive endo-lysophagy. Journal of Pharmaceutical Analysis, 16(10), 101672. https://doi.org/10.1016/j.jpha.2026.101672

Vancouver

Li C, Xu M, Ji Y, Deng C, Wan S, Ding X, et al. Cyclovirobuxine D suppresses gastric cancer growth by targeting the V-ATPase complex and inducing excessive endo-lysophagy. Journal of Pharmaceutical Analysis. 2026;16(10):101672. doi:10.1016/j.jpha.2026.101672

BibTeX
@article{Li2026,
  author = {Li, Chongyang and Xu, Minghao and Ji, Yacong and Deng, Chaowei and Wan, Sicheng and Ding, Xiangfei and Zhang, Kui and Zhao, Erhu and Pan, Guangzhao and Hu, Xin and Li, Changhong and Ji, Haoyan and Hu, Xiaosong and Shi, Shaomin and Cui, Hongjuan},
  title = {Cyclovirobuxine D suppresses gastric cancer growth by targeting the V-ATPase complex and inducing excessive endo-lysophagy},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {101672},
  doi = {10.1016/j.jpha.2026.101672}
}
Kostenlos starten →